David Toung
Stock Analyst at Argus Research
(4.50)
# 1,020
Out of 4,460 analysts
334
Total ratings
63%
Success rate
8.8%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IART Integra LifeSciences Holdings | Upgraded: Buy | $25 | $17.96 | +39.20% | 7 | Jun 17, 2026 | |
| LH Labcorp Holdings | Maintained: Buy | $310 | $280.00 | +10.71% | 3 | Jun 2, 2026 | |
| IQV IQVIA Holdings | Maintained: Buy | n/a | $193.22 | - | 5 | May 29, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | n/a | $90.46 | - | 2 | May 21, 2026 | |
| PFE Pfizer | Maintained: Buy | $35 | $24.08 | +45.35% | 12 | May 6, 2026 | |
| BSX Boston Scientific | Rated: Buy | $130 → $95 | $42.68 | +122.59% | 10 | Apr 24, 2026 | |
| DHR Danaher | Rated: Buy | $265 → $230 | $190.48 | +20.75% | 5 | Apr 23, 2026 | |
| UNH UnitedHealth Group | Upgraded: Buy | $400 | $415.63 | -3.76% | 14 | Apr 21, 2026 | |
| MDT Medtronic | Maintained: Buy | $115 | $78.23 | +47.00% | 18 | Apr 6, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $290 → $180 | $151.33 | +18.95% | 16 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $400 | $282.98 | +41.35% | 19 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $95 | $64.01 | +48.41% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $77.15 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $397.22 | - | 21 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $68 | $70.65 | -3.75% | 10 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 | $226.79 | -11.81% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $610 | $501.36 | +21.67% | 9 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $253.97 | -17.31% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $570 → $775 | $755.60 | +2.57% | 15 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $386.73 | - | 5 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 | $90.74 | n/a | 12 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.48 | n/a | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $410 → $450 | $314.84 | n/a | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 → $175 | $211.95 | n/a | 2 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $978.12 | n/a | 1 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $389.89 | n/a | 4 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 → $520 | $397.68 | n/a | 8 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $150 | $86.09 | n/a | 15 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $665 → $770 | $1,199.43 | n/a | 9 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $265 → $300 | $362.12 | n/a | 5 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $125 | $128.50 | n/a | 10 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $75 | $126.34 | n/a | 11 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $57.62 | n/a | 6 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $140 | $251.64 | n/a | 14 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $156.72 | n/a | 2 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $237.56 | n/a | 10 | Aug 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $216.06 | n/a | 1 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $19 | $5.09 | n/a | 3 | Oct 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $21.32 | n/a | 3 | Aug 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $21 | $44.47 | n/a | 1 | Apr 5, 2016 |
Integra LifeSciences Holdings
Jun 17, 2026
Upgraded: Buy
Price Target: $25
Current: $17.96
Upside: +39.20%
Labcorp Holdings
Jun 2, 2026
Maintained: Buy
Price Target: $310
Current: $280.00
Upside: +10.71%
IQVIA Holdings
May 29, 2026
Maintained: Buy
Price Target: n/a
Current: $193.22
Upside: -
Edwards Lifesciences
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $90.46
Upside: -
Pfizer
May 6, 2026
Maintained: Buy
Price Target: $35
Current: $24.08
Upside: +45.35%
Boston Scientific
Apr 24, 2026
Rated: Buy
Price Target: $130 → $95
Current: $42.68
Upside: +122.59%
Danaher
Apr 23, 2026
Rated: Buy
Price Target: $265 → $230
Current: $190.48
Upside: +20.75%
UnitedHealth Group
Apr 21, 2026
Upgraded: Buy
Price Target: $400
Current: $415.63
Upside: -3.76%
Medtronic
Apr 6, 2026
Maintained: Buy
Price Target: $115
Current: $78.23
Upside: +47.00%
Becton, Dickinson and Company
Mar 20, 2026
Rated: Buy
Price Target: $290 → $180
Current: $151.33
Upside: +18.95%
Mar 17, 2026
Reiterated: Buy
Price Target: $280 → $400
Current: $282.98
Upside: +41.35%
Mar 3, 2026
Rated: Buy
Price Target: $110 → $95
Current: $64.01
Upside: +48.41%
Dec 12, 2025
Maintained: Buy
Price Target: n/a
Current: $77.15
Upside: -
Dec 8, 2025
Maintained: Hold
Price Target: n/a
Current: $397.22
Upside: -
Nov 20, 2025
Rated: Buy
Price Target: $65 → $68
Current: $70.65
Upside: -3.75%
Nov 17, 2025
Upgraded: Buy
Price Target: $200
Current: $226.79
Upside: -11.81%
Oct 28, 2025
Maintained: Buy
Price Target: $610
Current: $501.36
Upside: +21.67%
Oct 14, 2025
Maintained: Buy
Price Target: $210
Current: $253.97
Upside: -17.31%
Aug 20, 2025
Rated: Buy
Price Target: $570 → $775
Current: $755.60
Upside: +2.57%
Jul 21, 2025
Downgraded: Hold
Price Target: n/a
Current: $386.73
Upside: -
Apr 21, 2025
Maintained: Buy
Price Target: $150
Current: $90.74
Upside: n/a
Mar 26, 2025
Maintained: Hold
Price Target: n/a
Current: $8.48
Upside: n/a
Feb 3, 2025
Maintained: Buy
Price Target: $410 → $450
Current: $314.84
Upside: n/a
Oct 24, 2024
Maintained: Buy
Price Target: $165 → $175
Current: $211.95
Upside: n/a
Aug 15, 2024
Rated: Buy
Price Target: n/a
Current: $978.12
Upside: n/a
Aug 1, 2024
Maintained: Buy
Price Target: n/a
Current: $389.89
Upside: n/a
Jul 23, 2024
Maintained: Buy
Price Target: $450 → $520
Current: $397.68
Upside: n/a
May 20, 2024
Upgraded: Buy
Price Target: $150
Current: $86.09
Upside: n/a
Feb 7, 2024
Maintained: Buy
Price Target: $665 → $770
Current: $1,199.43
Upside: n/a
Nov 6, 2023
Maintained: Buy
Price Target: $265 → $300
Current: $362.12
Upside: n/a
Jun 6, 2023
Maintained: Buy
Price Target: $115 → $125
Current: $128.50
Upside: n/a
Jan 28, 2022
Upgraded: Buy
Price Target: $75
Current: $126.34
Upside: n/a
Nov 1, 2021
Downgraded: Hold
Price Target: n/a
Current: $57.62
Upside: n/a
Aug 5, 2021
Maintained: Buy
Price Target: $115 → $140
Current: $251.64
Upside: n/a
Mar 10, 2021
Downgraded: Hold
Price Target: n/a
Current: $156.72
Upside: n/a
Aug 27, 2019
Downgraded: Hold
Price Target: n/a
Current: $237.56
Upside: n/a
Feb 16, 2018
Downgraded: Hold
Price Target: n/a
Current: $216.06
Upside: n/a
Oct 21, 2016
Reiterated: Buy
Price Target: $17 → $19
Current: $5.09
Upside: n/a
Aug 15, 2016
Maintained: Hold
Price Target: n/a
Current: $21.32
Upside: n/a
Apr 5, 2016
Downgraded: Hold
Price Target: $21
Current: $44.47
Upside: n/a